Bayer wins US priority review of drug against metastatic prostate cancer
Zydus receives DCGI approval for Oxemia to treat anaemia in CKD patients
Zydus develops new treatment for patients suffering from Chronic Kidney Disease (CKD)
FDA approves Dr Reddy’s NDA for migraine drug
Will NDA-2’s first budget be any different for the pharma sector?